Work

Abstract PS2-08-16: Validation of a multi-omic biosignature to predict locoregional recurrence risk and the benefit of adjuvant radiation therapy in women with early-stage invasive breast cancer treated with breast-conserving surgery and endocrine therapy

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-08-16

Authors: G. Mann, K. Mittal, R. de Boer, C. MacCallum, M. Alvarado, M. Christie, F. Vicini, C. Shah, Y. V. Zou, M. Mentrikoski, J. Savala, D. Dabbs, S. C. Shivers, P. Whitworth, T. Bremer

Institutions: Royal Women's Hospital, PreludeDx (United States), The Royal Melbourne Hospital, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Michigan Healthcare Professionals, Allegheny Health Network, GenesisCare

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130714580

Cites:

Cited by:

Related to: